Antares Pharma, Inc. v. Medac Pharma, Inc.
District Court, D. Delaware
1Opinion of the Court
MEMORANDUM OPINION
ROBINSON, District Judge
I. INTRODUCTION
On February, 28, 2014, plaintiff Antares Pharma, Inc. (“Antares”) filed a complaint alleging infringement of U.S. Patent Nos. 6,565,553 (“the ’553 patent”) and 8,480,631 (“the ’631 patent”) by defendants Medac Pharma, Inc. (“Medac Pharma”) and me-dac GmbH, (collectively “Medac”). (D.I. 1) Antares filed a motion for preliminary injunction directed to the ’553 and ’631 patents on March 14, 2014. (D.I. 6) On April 18, 2014, Antares amended its complaint, adding allegations of infringement of U.S. Patent Nos. RE 44,846 (“the ’846 patent”), *529a…
2Cases cited12 opinions
- Nutrition 21 v. The United States of America v. Thorne Research, Inc., Albert F. CzapCourt of Appeals for the Federal Circuit · 1991
- Abbott Laboratories v. Sandoz, Inc.Court of Appeals for the Federal Circuit · 2008
- Celsis in Vitro, Inc. v. CellzDirect, Inc.Court of Appeals for the Federal Circuit · 2012
- Mckeesport Hospital v. The Accreditation Council For Graduate Medical EducationCourt of Appeals for the Third Circuit · 1994
- North American Container, Inc. v. Plastipak Packaging, Inc.Court of Appeals for the Federal Circuit · 2005
7 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
- Takeda Pharmaceuticals USA, Inc. v. West-Ward Pharmaceutical Corp.District Court, D. Delaware · 2014
- LEE v. GALLINA-MECCADistrict Court, D. New Jersey · 2021
- RISIS v. SOLAKIANDistrict Court, D. New Jersey · 2023
- SHIVANANJAPPA v. RAJENDRADistrict Court, D. New Jersey · 2021
1 more not listed; retrieve them via the Exa API.